Syndax Pharmaceuticals Inc

MetLife Investment Management, LLC SNDX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

49,732

Value ($000)

1,045

Weight

0.0%

2020 Q1 - 2025 Q4 (24 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	1,045	0.0%	49,732	12/31/2025
2025 Q3	11/13/2025	765	0.0%	49,732	9/30/2025
2025 Q2	8/13/2025	466	0.0%	49,732	6/30/2025
2025 Q1	5/14/2025	611	0.0%	49,732	3/31/2025
2024 Q4	2/13/2025	668	0.0%	50,515	12/31/2024
2024 Q3	11/13/2024	915	0.0%	47,554	9/30/2024
2024 Q2	8/13/2024	976	0.0%	47,554	6/30/2024
2024 Q1	5/14/2024	960	0.0%	40,324	3/31/2024
2023 Q4	4/22/2024	751	0.0%	34,755	12/31/2023
2023 Q3	5/9/2024	505	0.0%	34,755	9/30/2023
2023 Q2	4/29/2024	727	0.0%	34,755	6/30/2023
2023 Q1	5/9/2024	668	0.0%	31,629	3/31/2023
2022 Q4	5/10/2024	711	0.0%	27,927	12/31/2022
2022 Q3	5/10/2024	650	0.0%	27,029	9/30/2022
2022 Q2	5/10/2024	520	0.0%	27,029	6/30/2022
2022 Q1	5/10/2024	470	0.0%	27,029	3/31/2022
2021 Q4	5/17/2024	373	0.0%	17,053	12/31/2021
2021 Q3	5/17/2024	326	0.0%	17,053	9/30/2021
2021 Q2	5/17/2024	293	0.0%	17,053	6/30/2021
2021 Q1	5/17/2024	251	0.0%	11,215	3/31/2021
2020 Q4	5/24/2024	249	0.0%	11,215	12/31/2020
2020 Q3	5/24/2024	166	0.0%	11,215	9/30/2020
2020 Q2	5/24/2024	166	0.0%	11,215	6/30/2020
2020 Q1	7/12/2023	123	0.0%	11,215	3/31/2020